U.S. Oil and Gas Stock News

NYSE:CUBI
NYSE:CUBIBanks

Customers Bancorp Buyback Tests Balance Between Capital Returns And Growth

Customers Bancorp (NYSE:CUBI) has launched a new $100 million share repurchase program authorized by its Board of Directors. The buyback gives the bank a flexible tool to manage capital while signaling confidence in its financial position. The authorization comes as Customers Bancorp continues to focus on supporting clients and long term growth plans. Customers Bancorp, trading at $71.67, has seen its share price move around recently, with a 7 day return of 6.6% decline and a 30 day return...
NYSE:XIFR
NYSE:XIFRRenewable Energy

Assessing XPLR Infrastructure (XIFR) Valuation After Mixed Q4 Results And Credit Facility Amendment

XPLR Infrastructure (XIFR) is back on investors’ radar after Q4 2025 results showed a shift to quarterly profitability, along with a newly amended revolving credit facility aimed at reshaping its balance sheet and liquidity profile. See our latest analysis for XPLR Infrastructure. Despite a 3.9% one day share price decline to US$10.65 after the Q4 report, XPLR Infrastructure’s 7 day share price return of 8.5% and 90 day gain of 13.4% suggest improving momentum, set against a 1 year total...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Balances VOXZOGO Canada Win With Debt Funded Amicus Expansion

BioMarin Pharmaceutical (NasdaqGS:BMRN) received a Notice of Compliance with Conditions from Health Canada for VOXZOGO, expanding access to its achondroplasia treatment in Canada. The company is progressing a large notes offering intended to help fund its pending acquisition of Amicus Therapeutics. These developments come as BioMarin shares trade at $59.94, with a 4.9% return over the past week and 8.6% over the past month. For you as an investor, BioMarin sits at an interesting point. The...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Assessing Beyond Meat (BYND) Valuation After Its Prolonged Share Price Weakness

Why Beyond Meat (BYND) Is Back on Many Watchlists Beyond Meat (BYND) has drawn fresh attention after its share price closed at US$0.69, with the stock showing mixed short term moves and deeper declines over the past year and past 3 months. See our latest analysis for Beyond Meat. That recent close at US$0.6915 comes after a 3.81% 7 day share price return, but a 26.98% 30 day and 35.97% 90 day share price decline, alongside a much deeper 82.09% 1 year total shareholder return loss that has...
NYSE:NI
NYSE:NIIntegrated Utilities

NiSource Taps Amazon Data Centers To Anchor Long Term Growth Plan

NiSource (NYSE:NI) has secured a long term electricity supply contract with Amazon subsidiary ADS for its data centers. The agreement covers utility scale power needs that are expected to support ADS facilities over multiple years. The deal is described by NiSource as a transformational step in its infrastructure investment and growth plans. NiSource runs regulated utility operations, and this contract ties that core business directly to the ongoing build out of data center capacity. As...
NYSE:ETR
NYSE:ETRElectric Utilities

Is Entergy (ETR) Pricing Fair After Strong Multi Year Share Price Gains?

If you are wondering whether Entergy's current share price really reflects its underlying value, you are not alone. This article is built to help you put a clear number on that question. Entergy's stock last closed at US$101.96, with returns of 5.2% over the past 7 days, 8.0% over 30 days, 8.6% year to date, 25.8% over 1 year, 109.7% over 3 years and 160.2% over 5 years. This raises fair questions about how much of the story is already priced in. Recent coverage around regulated utilities...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

DocuSign AI eSignature Push Raises Questions On Value And Profitability

DocuSign (NasdaqGS:DOCU) has launched new AI powered eSignature features as part of its Intelligent Agreement Management platform. The new tools focus on contract specific AI support to simplify legal documentation and address workflow friction for enterprises. The update introduces enhanced eSignature capabilities designed to improve how organizations manage and execute agreements. For you as an investor, this move sits squarely in the core line of business for DocuSign: digital agreement...
NYSE:CCO
NYSE:CCOMedia

Clear Channel Outdoor Buyout Tests Deal Certainty Versus Valuation Upside

Clear Channel Outdoor Holdings (NYSE:CCO) agreed to be acquired by Mubadala Capital and TWG Global in a US$6.2b go private transaction. The deal includes a 45 day go shop period that allows Clear Channel Outdoor to seek alternative acquisition proposals. Leadership changes are planned after closing, including the appointment of an executive chairman, with the transaction subject to shareholder and regulatory approval. Clear Channel Outdoor Holdings operates outdoor advertising assets such...
NYSE:TDY
NYSE:TDYElectronic

Teledyne Infrared Push Highlights Space Missile Tracking And Imaging Scale

Teledyne Technologies (NYSE:TDY) has begun production of advanced infrared Focal Plane Modules for the U.S. Space Development Agency’s missile tracking satellite constellation. The company is supplying next generation infrared technology intended to support space based missile warning and defense capabilities. Teledyne’s FLIR OEM business is being highlighted for its vertically integrated thermal imaging production and its ability to scale output rapidly. For you as an investor, this...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align’s Swiss Oral Health Study Puts Digital Tools And Growth Story To Test

Align Technology is partnering with the University of Bern on Switzerland's first comprehensive Swiss Oral Health Study. The project uses Align's iTero Lumina digital scanners and mobile dental vans to collect real time oral health data across the country. The collaboration focuses on preventive care insights and broader public health impact beyond Align's core orthodontic products. For investors watching NasdaqGS:ALGN, this research tie up sits alongside a share price of $183.86 and mixed...
NYSE:CALY
NYSE:CALYLeisure

Callaway Golf Refocuses On Core Equipment With Net Cash And Buybacks

Callaway Golf (NYSE:CALY) has refocused on its core golf equipment business by selling a majority stake in Topgolf and divesting Jack Wolfskin. The company reports a reduction of $1b in debt and a move to a net cash position following these transactions. Callaway Golf has also launched a $200m share repurchase program, signaling a shift in its approach to capital returns. For investors tracking NYSE:CALY, the story is now centered squarely on golf equipment, not adjacent leisure or apparel...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems (INSP) Q4 Margin Surge To 15.9% Tests Cautious Earnings Narratives

Inspire Medical Systems (INSP) has wrapped up FY 2025 with Q4 revenue of US$269.1 million and basic EPS of US$4.70, alongside net income of US$136.1 million. Its trailing 12 month figures show revenue of US$912.0 million and basic EPS of US$4.95. The company has seen revenue move from US$802.8 million to US$912.0 million on a trailing 12 month basis, with basic EPS shifting from US$1.80 to US$4.95 over the same period. This sets the stage for investors to focus on how much of that growth is...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Systems (CSCO) Margin Gains Reinforce Bullish AI And Security Narratives

Cisco Systems (CSCO) has just posted Q2 2026 results with revenue of US$15.3b and basic EPS of US$0.80, supported by net income of US$3.2b, giving investors a fresh read on how its core business is performing. The company has seen quarterly revenue move from US$14.0b and EPS of US$0.61 in Q2 2025 to US$15.3b and EPS of US$0.80 in Q2 2026. Trailing twelve month net profit margin sits at 18.8% versus 17% a year earlier, indicating a period where profitability has become more efficient even as...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

A Look At Cellebrite DI (CLBT) Valuation After 2026 Guidance And Forensics Acquisitions

Cellebrite DI (NasdaqGS:CLBT) drew fresh attention after reporting 2025 results and issuing 2026 guidance that points to higher annual recurring revenue, improved profitability, and continued cloud adoption, alongside acquisitions in Corellium and SCG Canada. See our latest analysis for Cellebrite DI. The latest guidance and acquisition news land after a choppy spell for the stock, with a 30 day share price return of 24% decline and a 1 year total shareholder return of 36.9% decline. However,...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

Assessing DiDi Global (OTCPK:DIDI.Y) Valuation After The Proposed US$740 Million Class Action Settlement

Understanding the proposed class action settlement The proposed US$740m class action settlement involving DiDi Global (DIDI.Y) is a key legal development for anyone following the stock, because it aims to resolve all claims tied to the case. If approved by the United States District Court for the Southern District of New York, the settlement would close a long running legal chapter for purchasers of the company’s American Depositary Shares. See our latest analysis for DiDi Global. The...
NYSE:ARE
NYSE:AREHealth Care REITs

Alexandria Balances Investor Lawsuit With Large Debt Refinancing Shift

Alexandria Real Estate Equities (NYSE:ARE) is facing an investor lawsuit alleging misrepresentation of leasing spreads, tenant pipeline, and occupancy at a Long Island City property. The complaint cites potential securities law violations and focuses on whether key property metrics were accurately communicated to shareholders. At the same time, the company is pursuing multiple refinancing actions, including an upsized tender for existing notes and a new $750 million senior note issue. For...
NYSE:HUBS
NYSE:HUBSSoftware

HubSpot (HUBS) Q4 EPS Surge Challenges Cautious Profitability Narratives

HubSpot (HUBS) has wrapped up FY 2025 with Q4 revenue of US$846.7 million and basic EPS of US$1.04, alongside trailing 12 month revenue of about US$3.1 billion and basic EPS of US$0.88. This gives investors a clear read on the current earnings run rate. Over recent periods, the company has seen quarterly revenue move from US$703.2 million in Q4 2024 to US$846.7 million in Q4 2025, while quarterly basic EPS shifted from US$0.10 to US$1.04. The story now hinges on how consistently HubSpot can...
NYSE:HLT
NYSE:HLTHospitality

Is Hilton’s 2026 EPS Outlook and Capital Returns Strategy Altering The Investment Case For Hilton (HLT)?

In the past week, Hilton Worldwide Holdings reported fourth-quarter 2025 results, issued 2026 earnings guidance, affirmed a US$0.15 quarterly dividend, and disclosed progress on its multi-year share repurchase program, including buying back 2,778,512 shares for US$756.87 million in the fourth quarter. Alongside record adjusted EBITDA of US$3.70 billion and significant global expansion milestones, including nearly 100,000 new rooms added in 2025, Hilton’s more cautious 2026 earnings outlook...
NYSE:TPL
NYSE:TPLOil and Gas

Texas Pacific Land Data Center Pivot Meets Lofty Valuation And Insider Buying

Texas Pacific Land (NYSE:TPL) agreed to a US$50 million partnership with Bolt Data & Energy to build large scale data centers on its West Texas acreage. The arrangement includes equity participation and water supply rights contributed by Texas Pacific Land to support the new digital infrastructure projects. Major shareholder Horizon Kinetics is continuing to accumulate shares, signaling ongoing insider confidence alongside the new data center initiative. Texas Pacific Land has long been...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Does PECO’s 2026 NOI Outlook Reinforce the Bull Case For Necessity-Based Retail Centers?

Phillips Edison & Company, Inc. recently reported past fourth-quarter and full-year 2025 results showing higher revenue of US$187.86 million and net income of US$47.53 million for the quarter, and issued 2026 guidance targeting net income per share between US$0.74 and US$0.77. An interesting aspect of this update is that management’s 2026 outlook includes Same-Center NOI growth of 3.8%, aligned with its stated long-term 3% to 4% range, suggesting confidence in the underlying performance of...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Is Viking Therapeutics (VKTX) Pricing Reflecting Recent Drug Development Progress?

If you are wondering whether Viking Therapeutics is attractively priced or already reflects a lot of optimism, starting with a clear view of its valuation can help frame your next move. The stock last closed at US$30.49, with returns of 16.0% over the past 7 days, a 0.7% decline over 30 days, a 13.9% decline year to date, a 3.4% gain over 1 year and a very large 3 year gain, and a 5 year gain of just over 3x. Recent news flow around Viking Therapeutics has mainly focused on its drug...